KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBT Margin (2016 - 2025)

Historic EBT Margin for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to 9.69%.

  • Exact Sciences' EBT Margin rose 1131000.0% to 9.69% in Q4 2025 from the same period last year, while for Dec 2025 it was 6.28%, marking a year-over-year increase of 312800.0%. This contributed to the annual value of 6.28% for FY2025, which is 312800.0% up from last year.
  • Latest data reveals that Exact Sciences reported EBT Margin of 9.69% as of Q4 2025, which was up 1131000.0% from 2.09% recorded in Q3 2025.
  • Over the past 5 years, Exact Sciences' EBT Margin peaked at 0.17% during Q3 2023, and registered a low of 122.78% during Q4 2024.
  • For the 5-year period, Exact Sciences' EBT Margin averaged around 26.04%, with its median value being 15.65% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -1150000bps in 2024, then skyrocketed by 1131000bps in 2025.
  • Quarter analysis of 5 years shows Exact Sciences' EBT Margin stood at 47.46% in 2021, then surged by 50bps to 23.5% in 2022, then surged by 67bps to 7.79% in 2023, then plummeted by -1477bps to 122.78% in 2024, then skyrocketed by 92bps to 9.69% in 2025.
  • Its EBT Margin was 9.69% in Q4 2025, compared to 2.09% in Q3 2025 and 0.01% in Q2 2025.